Active substance master file procedure - Scientific guideline

This guideline applies to human and veterinary medicines.

The main objective of the Active Substance Master File (ASMF) procedure, formerly known as the European Drug Master File (EDMF) procedure, is to allow valuable confidential intellectual property or 'know-how' of the manufacturer of the active substance (ASM) to be protected, while at the same time allowing the Applicant or Marketing Authorisation (MA) holder to take full responsibility for the medicinal product and the quality and quality control of the active substance. National Competent Authorities/EMA thus have access to the complete information that is necessary for an evaluation of the suitability of the use of the active substance in the medicinal product.

Keywords: Active substance master file (ASMF), letter of access, submission letter

Document history


How useful was this page?

Add your rating
9 ratings
1 rating
6 ratings